I am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, stress testing, and regulatory finance, developing a deep expertise in both fundamental and technical analysis. Alongside my research partner (also my wife), I co-author investment research, com ...

I issued a sell call on the Vanguard International Dividend Appreciation Index Fund ETF ( VIGI ) in June last year, at a time when the US growth markets looked decidedly a better place to be. TheI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, ...

I am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, stress testing, and regulatory finance, developing a deep expertise in both fundamental and technical analysis. Alongside my research partner (also my wife), I co-author investment research, com ...

On paper, the methodology embedded in the Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF ( QDPL ) looks very promising compared to covered call-based strategies. This is because it appears to allow undeterred upside captureI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barcl ...

Core Insights - The article emphasizes the importance of quantitative research, financial modeling, and risk management in equity valuation and market trends to identify high-growth investment opportunities [1]. Group 1: Company Expertise - The company has over 20 years of experience in quantitative research and financial modeling, focusing on equity valuation and market trends [1]. - The former Vice President at Barclays led teams in model validation, stress testing, and regulatory finance, showcasing deep expertise in both fundamental and technical analysis [1]. - The research is co-authored with a partner, combining complementary strengths to deliver high-quality, data-driven insights [1]. Group 2: Research Approach - The approach blends rigorous risk management with a long-term perspective on value creation [1]. - There is a particular interest in macroeconomic trends, corporate earnings, and financial statement analysis, aiming to provide actionable ideas for investors [1].

In June last year, I had found the WisdomTree Equity Premium Income Fund ETF ( WTPI ) a Buy because of some unique offerings that stood out within the option based income strategy ETFs. TheI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, stres ...

I am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, stress testing, and regulatory finance, developing a deep expertise in both fundamental and technical analysis. Alongside my research partner (also my wife), I co-author investment research, com ...

Core Viewpoint - The investment debate surrounding Incyte (INCY) focuses on the potential loss of exclusivity for Jakafi in the US by 2028, which may overshadow the company's strong pipeline and growth in other existing products [1] Group 1: Company Analysis - Incyte's future performance may be underestimated due to the consensus estimates that do not fully account for its robust pipeline [1] - The company has existing products that are expected to contribute to growth, indicating potential resilience despite the loss of exclusivity for Jakafi [1] Group 2: Analyst Background - The analysis is conducted by a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management, emphasizing a focus on equity valuation and market trends [1] - The analyst has a background as a former Vice President at Barclays, leading teams in model validation and stress testing, which adds credibility to the insights provided [1]

Core Viewpoint - There is no immediate catalyst to accumulate UnitedHealth Group (UNH) stock, and the current recommendation is a Hold due to revenue slowdown and margin pressures [1] Company Analysis - UnitedHealth Group is experiencing a slowdown in revenue, which is a significant factor in the current investment outlook [1] - Immediate margin pressures are also impacting the stock's performance and investment recommendations [1] Analyst Background - The analysis is conducted by a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management, focusing on equity valuation and market trends [1] - The analyst has a background as a former Vice President at Barclays, leading teams in model validation and stress testing, indicating a strong expertise in both fundamental and technical analysis [1]

Group 1 - The article discusses various covered call income strategies and highlights the effectiveness of YieldMax ETFs in capturing upside potential while being reliable for long-term investment [1] - The author emphasizes a focus on equity valuation, market trends, and portfolio optimization to identify high-growth investment opportunities [1] - The research approach combines rigorous risk management with a long-term perspective on value creation, particularly interested in macroeconomic trends and corporate earnings [1]